Noticias de BTAI_US

Noticias del mercado

Últimas noticias sobre BTAI_US — 179 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BTAI_US ✕ 179 resultados
28/05/2026 BTAI_US — Investing.com
BioXcel presents data on at-home agitation treatment trial By Investing.com
28/05/2026 BTAI_US — GlobeNewswire
BioXcel Therapeutics Presents New Data from SERENITY
27/05/2026 BTAI_US — Moomoo ES ← EN
Introducción y perfil de la empresa BioXcel Therapeutics

BioXcel Therapeutics Company Profile & Introduction

23/05/2026 BTAI_US — Investing.com ES ← EN
Frank Yocca, CSO de BioXcel Therapeutics, vende acciones de la empresa por valor de 7.426 dólares Por Investing.com

BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock By Investing.com

23/05/2026 BTAI_US — Investing.com Australia ES ← EN
Mehta, director ejecutivo de BioXcel Therapeutics, vende acciones de la empresa por valor de 21.108 dólares Por Investing.com

BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com

23/05/2026 BTAI_US — Investing.com
BioXcel Therapeutics chief legal officer sells $7,111 in stock By Investing.com
23/05/2026 BTAI_US — Investing.com
BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com
23/05/2026 BTAI_US — Investing.com
BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com
23/05/2026 BTAI_US — Investing.com
BioXcel CFO Richard Steinhart sells $7,426 of stock By Investing.com
23/05/2026 BTAI_US — Investing.com Nigeria
BioXcel CFO Richard Steinhart sells $7,426 of stock By Investing.com
23/05/2026 BTAI_US — Investing.com Australia
BioXcel CFO Richard Steinhart sells $7,426 of stock By Investing.com
23/05/2026 BTAI_US — Investing.com Canada ES ← EN
El director jurídico de BioXcel Therapeutics vende acciones por valor de 7.111 dólares Por Investing.com

BioXcel Therapeutics chief legal officer sells $7,111 in stock By Investing.com

22/05/2026 BTAI_US — Investing.com ES ← EN
Frank Yocca, CSO de BioXcel Therapeutics, vende acciones de la empresa por valor de 7.426 dólares Por Investing.com

BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock By Investing.com

22/05/2026 BTAI_US — Investing.com India ES ← EN
Frank Yocca, CSO de BioXcel Therapeutics, vende acciones de la empresa por valor de 7.426 dólares Por Investing.com

BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock By Investing.com

22/05/2026 BTAI_US — Investing.com ES ← EN
El director jurídico de BioXcel Therapeutics vende acciones por valor de 7.111 dólares Por Investing.com

BioXcel Therapeutics chief legal officer sells $7,111 in stock By Investing.com

22/05/2026 BTAI_US — Investing.com India ES ← EN
Mehta, director ejecutivo de BioXcel Therapeutics, vende acciones de la empresa por valor de 21.108 dólares Por Investing.com

BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com

22/05/2026 BTAI_US — Investing.com ES ← EN
Mehta, director ejecutivo de BioXcel Therapeutics, vende acciones de la empresa por valor de 21.108 dólares Por Investing.com

BioXcel Therapeutics CEO Mehta sells $21,108 in company stock By Investing.com

22/05/2026 BTAI_US — Investing.com South Africa ES ← EN
Frank Yocca, CSO de BioXcel Therapeutics, vende acciones de la empresa por valor de 7.426 dólares Por Investing.com

BioXcel Therapeutics CSO Frank Yocca sells $7,426 in company stock By Investing.com

22/05/2026 BTAI_US — Investing.com ES ← EN
El director financiero de BioXcel, Richard Steinhart, vende acciones por valor de 7.426 dólares

BioXcel CFO Richard Steinhart sells $7,426 of stock

22/05/2026 BTAI_US — Investing.com ES ← EN
El director financiero de BioXcel, Richard Steinhart, vende acciones por valor de 7.426 dólares Por Investing.com

BioXcel CFO Richard Steinhart sells $7,426 of stock By Investing.com

Página 2 de 9

keyboard_arrow_up